SEC Filings TLDR

Atlas Venture Opportunity Fund II, L.P. has filed a Form 144 with the SEC, indicating its intention to sell 10,604 shares of Sionna Therapeutics, Inc. common stock. The shares were acquired through a private placement on March 4, 2024. The notice, signed by Ommer Chohan, was dated October 17, 2025, with the plan adopti...

Atlas Venture Fund XI, LP has filed a Form 144 with the SEC, indicating its intention to sell 50,520 shares of Sionna Therapeutics, Inc. common stock. The shares were acquired through a private placement on March 4, 2024. The filing also details recent sales of Sionna Therapeutics, Inc. common stock by Atlas Venture Fu...

The filing details the securities transactions of Matthew Link, an officer of Sight Sciences, Inc. It includes the vesting of 10,529 restricted common stock units on October 9, 2025, as part of compensation. The filing also reports the sale of 81,743 common stock units over the past three months, with gross proceeds to...

Kasibhatla Vijay, a former officer of SLB Limited, has filed a Form 144 notice indicating the planned sale of 29,000 shares of common stock. The shares were acquired through compensation in the form of performance units and restricted stock vesting, with acquisition dates ranging from January 2022 to January 2024. The ...

Eric Venker, an officer of Roivant Sciences Ltd., has filed a Form 144 to report the planned sale of 118,418 common shares. The shares will be sold pursuant to a Rule 10b5-1 trading plan adopted on March 28, 2025. The sale is expected to occur on October 17, 2025, with an aggregate market value of approximately $2,020,...

Sandford Helene Gail, a director of Rigetti Computing, Inc., has filed a Form 144 notice indicating her intention to sell 62,000 shares of the company's common stock. The shares were acquired on June 1, 2024, as part of her compensation. The planned sale is expected to occur around October 17, 2025, with an aggregate m...

Mark A Goldsmith, a director and officer of Revolution Medicines Inc, has filed a Form 144 detailing his stock transactions. On 10/17/2025, Goldsmith exercised stock options to acquire 10,000 shares of common stock. Additionally, he sold 10,000 shares on 10/16/2025 for a total value of $504,701.00 and 13,411 shares on ...

Jeffrey Todd Cislini, an officer at Revolution Medicines Inc, has filed a Form 144 notice detailing his stock transactions. On October 17, 2025, Cislini exercised stock options to acquire 12,000 shares of common stock. Additionally, he sold 1,799 shares on September 24, 2025, for $79,623.74 and 1,869 shares on Septembe...

The filing details the securities transactions of Balaji Gandhi, an officer at Phreesia, Inc. On October 17, 2025, Gandhi sold 885 shares of common stock, which were acquired through restricted stock vesting on October 14, 2025. The sale was necessary to cover a tax obligation resulting from the settlement of the veste...

The filing details the securities transactions of Chaim Indig, an officer and director of Phreesia, Inc. On October 17, 2025, Indig sold 3,163 shares of common stock, valued at $70,728.48, to cover tax obligations from a vested equity award. The shares were acquired on October 14, 2025, through restricted stock vesting...

The filing details the stock transactions of Allison C. Hoffman, an officer at Phreesia, Inc. On October 14, 2025, Hoffman acquired 1,241 shares of common stock through restricted stock vesting as part of compensation. These shares are to be sold on October 17, 2025, with an aggregate market value of $27,750.25. The sa...

The filing details the securities transactions of David Linetsky, an officer of Phreesia, Inc. It includes the sale of 2,059 common shares on October 17, 2025, with an aggregate market value of $46,041.71. The shares were acquired through restricted stock vesting on October 14, 2025. The sale was necessary to cover a t...

Amy VanDuyn, an officer at Phreesia, Inc., reported the vesting of 639 shares of common stock on October 14, 2025, as part of her compensation. The shares were subsequently sold on October 17, 2025, with an aggregate market value of $14,288.81. The sale included an amount necessary to cover a tax obligation resulting f...

Evan Roberts, an officer of Phreesia, Inc., has reported the sale of 1,888 common shares on October 17, 2025, with an aggregate market value of $42,217.95. The shares were acquired on October 14, 2025, through restricted stock vesting as part of compensation. Additionally, Roberts has sold a significant number of share...

Megan Chung, an officer of Ouster, Inc., has filed a Form 144 with the SEC detailing a plan to sell securities. The filing outlines the acquisition of restricted stock units (RSUs) on multiple dates, including 09/11/2022, 12/11/2022, 03/28/2024, and 03/11/2023, totaling 5,838 units. The securities are to be sold on or ...

Robert F. Helm, an officer at Ollies Bargain Outlet Holdings, Inc., has exercised stock options for 1,493 shares of common stock on October 17, 2025. The stock options were originally acquired on the same date, and the transaction was executed at a market value of $183,833.09. The shares are traded on NASDAQ, and the t...

Mark D Gordon, a director and officer of Odyssey Marine Exploration, Inc., has filed a Form 144 notice indicating his intention to sell 30,000 shares of common stock acquired through the vesting of restricted stock units. The shares were originally acquired on December 20, 2016, and the sale is planned for October 17, ...

HUANG JEN HSUN, President and CEO of NVIDIA CORP, has filed a notice of sale of 75,000 shares of NVIDIA CORP common stock. The shares were acquired on 03/17/2021 through a Restricted Stock Lapse. The sale is scheduled for 10/17/2025, with an aggregate market value of $13,673,241.00. Additionally, HUANG JEN HSUN has rep...

Daniel Danker, a former affiliate of Maplebear Inc., has filed a Form 144 to sell 8,162 shares of Maplebear Inc. common stock. The shares are to be sold pursuant to a Rule 10b5-1 trading plan, which was adopted on February 28, 2025. The shares were acquired on August 15, 2025, through the lapse of restricted stock. The...

Morgan Stanley Smith Barney LLC has filed a Form 144 with the SEC, indicating the intention to sell 3,320 shares of Morgan Stanley common stock. The shares were acquired through the facilitation of customer liquidations of fractional shares between July 10, 2025, and October 9, 2025. These fractional shares were obtain...

Frederick Thiel, an officer and director of MARA Holdings, Inc., has reported the sale of 27,505 common shares on October 17, 2025, through The Thiel Living Trust, where he serves as a trustee and account stakeholder. The shares were acquired on January 31, 2024, as part of restricted stock vesting. The aggregate marke...

Eric Adler, an officer at Lexeo Therapeutics, Inc., has reported the vesting and subsequent sale of restricted stock. On October 15, 2025, Adler acquired 3,382 shares of common stock through restricted stock vesting as part of his compensation. These shares were then sold on October 17, 2025, with an aggregate market v...

Jose Manuel Otero, an officer at Lexeo Therapeutics, Inc., has reported the sale of 2,115 shares of common stock on October 17, 2025, with an aggregate market value of $18,912.54. The shares were acquired through the vesting of restricted stock on October 15, 2025, as part of compensation. Additionally, Otero sold 2,84...

Jenny Robertson, an officer at Lexeo Therapeutics, Inc., has reported the sale and vesting of common stock. On October 15, 2025, Robertson vested 3,526 shares of restricted stock as part of her compensation. These shares were acquired from the issuer. Additionally, Robertson sold 542 shares on August 18, 2025, generati...

Richard N. Townsend, an officer and director of Lexeo Therapeutics, Inc., reported the sale of 13,133 common shares on October 17, 2025, with an aggregate market value of $117,436.60. The shares were acquired through restricted stock vesting on October 15, 2025, as part of compensation. Additionally, Townsend sold 1,11...